Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jefferson City, MO
NPI
1568442267
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1241 W Stadium Blvd
Jefferson City, MO, 65109
Phone (573) 635-5264
Groups this clinician bills Medicare through
Medicare paid, 2024
$130K
5,620 services
Medicare patients, 2024
503
Average age 74
Drug cost, 2024
$3.9M
10,770 prescriptions
Company payments, 2025
$68K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan T Rauba was code 36415 (venipuncture blood collection), 644 times for 383 patients. In total Alan T Rauba billed 5,620 services in 64 codes, and Medicare paid $130K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 644 | 383 | $8.63 | $5,556 |
| 99214 Office E&M - Established | Office | 502 | 385 | $77.90 | $39K |
| 83036 Blood Count | Office | 421 | 267 | $9.49 | $3,994 |
| 84443 Clinical Chemistry | Office | 414 | 305 | $16.43 | $6,802 |
| 84481 Clinical Chemistry | Office | 397 | 295 | $16.57 | $6,577 |
| 84439 Clinical Chemistry | Office | 393 | 291 | $8.82 | $3,467 |
| 99454 E&M - Miscellaneous | Office | 355 | 59 | $31.74 | $11K |
| 95251 Test - Miscellaneous | Office | 349 | 107 | $24.49 | $8,548 |
| 80053 Clinical Chemistry | Office | 233 | 199 | $10.35 | $2,412 |
| 80061 Clinical Chemistry | Office | 174 | 166 | $13.12 | $2,283 |
| 82306 Clinical Chemistry | Office | 162 | 122 | $29.01 | $4,700 |
| 82607 Clinical Chemistry | Office | 160 | 141 | $14.64 | $2,343 |
| 80048 Clinical Chemistry | Office | 152 | 123 | $8.25 | $1,254 |
| 82570 Clinical Chemistry | Office | 137 | 127 | $5.05 | $692 |
| 82043 Clinical Chemistry | Office | 137 | 127 | $5.63 | $771 |
By year: 2022 $175K for 10,060 services; 2023 $134K for 6,725 services; 2024 $130K for 5,620 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 644 | 383 | $8.63 | $5,556 |
| 83036 Blood Count | 421 | 267 | $9.49 | $3,994 |
| 84443 Clinical Chemistry | 414 | 305 | $16.43 | $6,802 |
| 84481 Clinical Chemistry | 397 | 295 | $16.57 | $6,577 |
| 84439 Clinical Chemistry | 393 | 291 | $8.82 | $3,467 |
| 80053 Clinical Chemistry | 233 | 199 | $10.35 | $2,412 |
| 80061 Clinical Chemistry | 174 | 166 | $13.12 | $2,283 |
| 82306 Clinical Chemistry | 162 | 122 | $29.01 | $4,700 |
| 82607 Clinical Chemistry | 160 | 141 | $14.64 | $2,343 |
| 80048 Clinical Chemistry | 152 | 123 | $8.25 | $1,254 |
Medicare prescription drug claims, 2024
In 2024, the drug Alan T Rauba prescribed most often to Medicare patients was Levothyroxine Sodium, with 704 prescriptions and refills. In total Alan T Rauba wrote 10,770 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 704 | 1,861 | 190 | $7,765 |
| Jardiance Empagliflozin | 694 | 1,359 | 147 | $639K |
| Ozempic Semaglutide | 585 | 887 | 113 | $837K |
| Metformin Hcl Er Metformin Hcl | 539 | 1,438 | 140 | $6,058 |
| Farxiga Dapagliflozin Propanediol | 419 | 787 | 86 | $429K |
| Atorvastatin Calcium Generic | 381 | 1,094 | 107 | $4,408 |
| Glimepiride Generic | 344 | 953 | 102 | $2,785 |
| Trulicity Dulaglutide | 280 | 389 | 59 | $376K |
| Metformin Hcl Generic | 276 | 748 | 76 | $2,135 |
| Pioglitazone Hcl Generic | 272 | 748 | 77 | $2,885 |
| Rosuvastatin Calcium Generic | 257 | 728 | 76 | $3,799 |
| Lisinopril Generic | 237 | 633 | 67 | $1,996 |
| Np Thyroid Thyroid,pork | 227 | 572 | 63 | $20K |
| Mounjaro Tirzepatide | 194 | 244 | 42 | $253K |
| Losartan Potassium Generic | 180 | 467 | 49 | $1,751 |
Brand drugs: 4,133 claims; generic drugs: 6,052 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan T Rauba $68K ($68K in general payments such as food, travel and fees) from 20 companies. The largest payer was Novo Nordisk Inc with $40K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 62 | $40K |
| Lilly USA, LLC LLY | 63 | $26K |
| Tandem Diabetes Care, Inc. TNDM | 4 | $1,500 |
| Radius Health, Inc. | 11 | $139 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $48.32 |
| Xeris Pharmaceuticals, Inc. | 3 | $44.73 |
| Acella Pharmaceuticals, LLC | 2 | $39.46 |
| Amgen Inc. AMGN | 2 | $32.24 |
| GlaxoSmithKline, LLC. GSK | 2 | $30.06 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $28.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.